Literature DB >> 35216712

Fertility Considerations in Hypogonadal Men.

Nikoleta Papanikolaou1, Rong Luo1, Channa N Jayasena2.   

Abstract

Hypogonadism can be present in up to 40% in men who present with couple infertility. Testosterone is the major androgen regulating-spermatogenesis in men; as a result, men with either primary or secondary hypogonadism may be subfertile because of impaired spermatogenesis. The clinical impact of hypogonadism on fertility potential depends on the timing of its onset (fetal, prepubertal, or postpubertal) and effect on semen parameters. Treatment pathways and success rates differ according to the cause of hypogonadism and the time of its onset. When medical therapy fails to induce sufficient sperm, assisted reproductive technologies are considered.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aromatase inhibitors; GnRH; Gonadotropins; Hormone stimulation; Hypogonadal men; Hypogonadism; Male infertility; SERM

Mesh:

Substances:

Year:  2022        PMID: 35216712     DOI: 10.1016/j.ecl.2021.11.009

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  1 in total

Review 1.  Effectiveness of Clomiphene Citrate for Improving Sperm Concentration: A Literature Review and Meta-Analysis.

Authors:  Dragos Puia; Catalin Pricop
Journal:  Cureus       Date:  2022-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.